Archive for August, 2015

Northwest Biotherapeutics Alert – Investors encouraged to contact law firm

NORTHWEST BIOTHERAPEUTICS ALERT: National Securities Law Firm Announces Investigation of Potential Securities Claims, and Encourages Investors With Losses to Contact Law Firm for More Information

August 21, 2015
New York, New York

Tripp Levy PLLC, a leading national securities law firm, announces that it is investigating potential securities claims on behalf of investors of Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) (“Northwest” or the “Company”) resulting from allegations that Northwest may have issued materially misleading business information to the investing public.

On June 19, 2014, a report published by the website TheStreet.com stated that, “The prestigious MD Anderson Cancer Center issued a stern rebuke to Northwest Biotherapeutics (NWBO) for making promotional, unjustified claims about results from an ongoing clinical trial of an experimental cancer vaccine known as DCVax-Direct.” MD Anderson Cancer Center is running the DCVax-Direct clinical trial with funding from Northwest Biotherapeutics. On this news, shares of Northwest fell $0.87 per share to $8.04, or more than 10.37%, in intraday trading on June 19, 2014.

On July 7, 2014, a report published by the seekingalpha.com website stated that, “Northwest Bio has been the subject of a massive promotional campaign which has seen the stock price soar.” And, “in some cases, authors have used fictitious identities and fake credentials within healthcare or finance. In fact they are simply paid writers.” On this news, shares of Northwest fell $0.52 per share to $6.62, or more than 7.28%, in intraday trading on July 7, 2014.

On August 21, 2015, pre-market, news broke that the Company’s Phase 3 DCVax-L brain cancer treatment clinical trial in Germany was temporarily halted. A reason is yet to be provided, and Northwest is yet to address the issue publicly. On this news, Northwest shares fell as much as $0.88, or 9.91% during intraday trading on August 21, 2015.

If you purchased shares of Northwest and have suffered a loss from your investment in Northwest common stock and would like to learn more about this investigation, including your ability to potentially recover your losses, please contact us toll free at 1-800-511-7037 or contact us via our website or go to Participate in an Action.

Tripp Levy PLLC is a leading national securities and shareholder rights law firm representing both individual and institutional shareholders and, along with its affiliate, have recovered billions of dollars for shareholders. Tripp Levy PLLC is affiliated with Milberg LLP. The National Law Journal has named Milberg one of the “50 Elite Trial Lawyer Firms” and one of the “50 Leading Plaintiff Firms in America.”

Attorney advertising. Prior results do not indicate a similar outcome

On Deck Capital Alert – Investors encouraged to contact law firm

ON DECK CAPITAL ALERT: National Securities Law Firm Announces Filing of Lawsuit to Recover Losses, and Encourages Investors to Contact Law Firm for More Information

August 5, 2015
New York, New York

Tripp Levy PLLC, a leading national securities law firm, announces that a class action lawsuit has been filed against On Deck Capital, Inc. (“On Deck” or the “Company”) (ONDK) and certain of its officers. The class action, filed in United States District Court Southern District of New York, is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired On Deck securities pursuant and/or traceable to On Deck’s Registration Statement and Prospectus issued in connection with the Company’s December 16, 2014 initial public offering (“IPO”).

The Complaint alleges that defendants made materially false and misleading statements regarding the Company’s business, operational and compliance policies. Specifically, defendants made false and/or misleading statements and/or failed to disclose that: (1) the true rate of default for the Company’s loan portfolio was steadily increasing; (2) the true value of the Company’s loan portfolio was in material decline; and (3) as a result of the foregoing, On Deck’s public statements were materially false and misleading at all relevant times.

On December 15, 2014, On Deck filed its amended Registration Statement for the IPO, which became effective on December 17, 2014. On February 11, 2015, less than two months after the IPO, SeekingAlpha.com published an article entitled “On-Deck Capital: Bad Loans, Bad Interest Rates, Bad Business Plan.” The article described, in part, how the Company’s Registration Statement significantly understated the default rate for the Company’s loan portfolio.

On March 18, 2015, Compass Point Research & Trading, LLC (“Compass Point”) published a research report (the “Compass Point Report”) that detailed concerns with On Deck’s business model, including inherent risks surrounding an untested credit model, growing competition, uncertainty with regard to interest rates, and anticipated regulatory threats, all of which created a risky environment for On Deck investors. On Deck’s unsustainable business model, according to the Compass Point Report, could ultimately lead to slower growth and higher expenses.

On July 1, 2015, barely six months after the IPO, On Deck common stock dropped to a low of $11.15 per share, a decline of over 40% from the IPO price and of over 60% from its almost $29 per share high on December 18, 2014. The significant drop in share price came after news reports of rising default rates in On Deck’s loan portfolios and declining value of its business model. The Company is now reportedly losing tens of millions of dollars through defaults on its loans, likely due to the company’s reliance on stated income and data from third-party sources, which may contain inaccuracies.

If you purchased shares of On Deck pursuant and/or traceable to On Deck’s Registration Statement and Prospectus issued in connection with the Company’s December 16, 2014 initial public offering and have suffered a loss from your investment in On Deck common stock and would like to learn more about this lawsuit, including your ability to potentially recover your losses, please contact us toll free at 1-800-511-7037 or contact us via our website. In addition, if you wish to serve as lead plaintiff, you must move the Court no later October 3, 2015. You can join this class action to potentially recover your losses by contacting us to Participate in an Action.

Tripp Levy PLLC is a leading national securities and shareholder rights law firm representing both individual and institutional shareholders and, along with its affiliate, have recovered billions of dollars for shareholders. Tripp Levy PLLC is affiliated with Milberg LLP. The National Law Journal has named Milberg one of the “50 Elite Trial Lawyer Firms” and one of the “50 Leading Plaintiff Firms in America.”

Attorney advertising. Prior results do not indicate a similar outcome

AAC Holdings Shareholder Alert – Investors encouraged to contact law firm

AAC HOLDINGS ALERT: National Securities Law Firm Announces Investigation of Potential Securities Claims Against AAC Holdings, and Encourages Investors With Losses to Contact Law Firm for More Information

August 4, 2015
New York, New York

Tripp Levy PLLC, a leading national securities law firm, announces that it is investigating potential securities claims on behalf of investors of AAC Holdings, Inc. (NYSE: AAC) resulting from allegations that AAC may have issued materially misleading business information to the investing public.

On August 4, 2015, AAC announced that its former president has been indicted on a second-degree murder charge. The indictment relates to the death of a patient in 2010 at American Addiction Centers, to which AAC is a parent company. The indictment was brought against three former AAC employees, AAC president Jerrod Menz, and a current employee. Menz stepped down from his role as president, as well as from the board of directors, following the news.

On the announcement, shares of AAC fell as much as 53%, the biggest drop since AAC went public in October 2014. Trading on the stock has been temporarily halted.

If you purchased shares of AAC and have suffered a loss from your investment in AAC common stock and would like to learn more about this investigation, including your ability to potentially recover your losses, please contact us toll free at 1-800-511-7037 or contact us via our website.

Tripp Levy PLLC represents individual and institutional shareholders in mergers and acquisitions transactions and, along with its affiliate, has recovered billions of dollars for shareholders in securities actions around the globe. Tripp Levy PLLC is affiliated with the law firm Milberg LLP. The National Law Journal has named Milberg one of the “50 Elite Trial Lawyer Firms” and one of the “50 Leading Plaintiff Firms in America.” Attorney advertising. Prior results do not indicate a similar outcome.

^